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Abstract 
The COVID-19 pandemic has devastated the world with health and economic wreckage. 
Precise estimates of the COVID-19 adverse outcomes on individual patients could have led to 
better allocation of healthcare resources and more efficient targeted preventive measures. We 
developed MLHO (pronounced as melo) for predicting patient-level risk of hospitalization, ICU 
admission, need for mechanical ventilation, and death from patients’ past (before COVID-19 
infection) medical records. MLHO is an end-to-end Machine Learning pipeline that implements 
iterative sequential representation mining and feature and model selection to predict health 
outcomes. MLHO’s architecture enables a parallel and outcome-oriented calibration, in which 
different statistical learning algorithms and vectors of features are simultaneously tested and 
leveraged to improve prediction of health outcomes. Using clinical data from a large cohort of 
over 14,000 patients, we modeled the four adverse outcomes utilizing about 600 features 
representing patients’ before-COVID health records. Overall, the best predictions were obtained 
from extreme and gradient boosting models. The median AUC ROC for mortality prediction was 
0.91, while the prediction performance ranged between 0.79 and 0.83 for ICU, hospitalization, 
and ventilation. We broadly describe the clusters of features that were utilized in modeling and 
their relative influence on predicting each outcome. As COVID-19 cases are re-surging in the 
U.S. and around the world, a Machine Learning pipeline like MLHO is crucial to improve our 
readiness for confronting the potential future waves of COVID-19, as well as other novel 
infectious diseases that may emerge in the near future. 
 
 
 
 
 
 
 
 
 
 
 
  
Introduction  
The global spread of COVID-19, the disease caused by SARS-CoV-2, has resulted in the loss 
of around 700,000 lives. Repercussions of the pandemic have wreaked havoc on the economy, 
sending billions of people into lockdown to flatten the curve for the healthcare systems and 
resulting in record-high unemployment around the world. The American Hospital Association 
estimates a total four-month financial impact of over $200 billion in losses for the U.S. 
healthcare systems as a result of cancelled hospital services (e.g., cancelled non-elective 
surgeries and outpatient treatment) due to the COVID-19 pandemic and COVID-19 
hospitalizations.​1​ Our inability to provide precise estimates of the COVID-19 outcomes such as 
death, hospitalization, and need for ICU and ventilation has contributed to lost opportunities for 
saving lives with personalized preventive measures and making smart resource allocation 
plans. Although our inability to predict was partly due to the novelty of the disease, the critical 
question is: do we have the data and technology to predict? 
  
Over the past decade, the U.S. federal government has made extensive investments to institute 
meaningful use of electronic health record (EHR) systems. Clinical data in EHRs, however, are 
still complex and have important quality issues, impeding their leverage to address pressing 
health issues that require rapid response. Nevertheless, biomedical researchers are 
increasingly applying data mining and Machine Learning techniques to clinical data for 
predicting health outcomes. 
 
Recent studies have shown that COVID-19 disease severity and mortality are associated with a 
number of comorbidities including cardiovascular disease, diabetes mellitus, hypertension, 
chronic lung disease, cancer, chronic kidney disease, and obesity, and demographics including 
age, sex, and race/ethnicity.​2–8​ A number of Machine Learning (ML) models have been 
developed to predict susceptibility in the general population, the likelihood of a positive 
diagnosis in a patient with symptoms, and prognosis in those with the disease.​9​ Many of these 
models are based on a combination of demographics, comorbidities, symptoms, and 
biomarkers,​10–15​ and use data from relatively small cohorts of COVID-19 patients. Jiangfent et 
al,​10​ for example, performed a logistic regression analysis on 299 patients that identified age, 
lymphocyte count, lactate dehydrogenase, and oxygen saturation as independent predictors for 
mortality. Jiang et al,​15​ used data from 53 patients to develop ML models to identify elevated 
alanine aminotransferase (ALT), the presence of myalgias, and an elevated hemoglobin as the 
most predictive features for disease severity, achieving approximately 70-80% accuracy in 
modeling COVID-19 morality. Huang et al​11​ examined clinical data from 125 COVID-19 patients 
and identified the presence of comorbidities, increased respiratory rate, elevated C-reactive 
protein, and elevated lactate dehydrogenase as independently associated with a worse 
prognosis. While the inclusion of vital signs and biomarkers in these models may be highly 
predictive of some adverse outcomes of COVID-19 infection, they are typically measured after 
the patient has already started to show signs of the disease and may be at a point that is too 
late for a useful intervention.  
 
Estiri et al. recently introduced the transitive Sequential Pattern Mining (tSPM) along with a 
dimensionality reduction algorithm, MSMR, and showed that together, the algorithms can 
successfully predict different health outcomes.​16,17​ The goal in tSPM is to mine temporal data 
representations from clinical data for application in downstream ML. The number of transitive 
sequential representations is quadratic in the number of records, and thus create dimensionality 
issues. To address this, the MSMR algorithm -- short form stands for Minimize Sparsity, 
Maximize Relevance, applies high performance dimensionality reduction (Figure 1). It takes the 
initial set of N features mined by the tSPM algorithm and provides a list of <400 features, 
through a 3-step process including frequency-based and information-based (mutual information, 
and joint mutual information) filtering of a large number of features.​16,17 
 
We adapt the tSPM temporal representation mining and MSMR dimensionality reduction 
algorithms, and make adjustments to architect an end-to-end ML pipeline that enables iterative 
feature and algorithm selection to predict health outcomes (MLHO, pronounced as melo). 
MLHO offers an architecture that enables a parallel outcome-targeted calibration of the features 
and algorithms. The goal in MLHO is to mine relevant data representations from past clinical 
records and select the most efficient algorithmic solution for accurately predicting future health 
outcomes. As COVID-19 cases are rising again in many areas of the world, being able to 
provide personalized predictions of its adverse outcomes that are directly connected to the 
healthcare systems’ responsiveness and mortality can be game-changing. In this study, we 
focus on predicting four outcomes (hospitalization, ICU, ventilation, and death) in patients with a 
verified COVID-19 infection, using their past medical records. Using about 600 features mined 
from patients’ past medical records (before contracting COVID-19), we trained and tested 
predictive models that estimate risks of hospitalization, ICU admission, need for mechanical 
ventilation, and death. 
Method 
Implementation of the MLHO pipeline is depicted in Figure 1. MLHO mines both sequential 
(temporal) and raw data representations from clinical data and performs iterative feature and 
algorithm selection in a 2-step evaluation process. MLHO’s architecture enables a parallel 
outcome-targeted calibration of the features and algorithms, in which different statistical learning 
algorithms and vectors of features are simultaneously tested and leveraged to improve 
prediction of health outcomes. The four adverse outcomes of interest in this study reflect a 
hypothetical sequential spectrum of outcome severity in patients with verified COVID-19 
infection, ranging from hospitalization to ICU admission, to need for mechanical ventilation, and 
ultimately to death (Hospitalization → ICU → Ventilation → Death).  
 
 
 
Figure 1.​ Implementation of the MLHO pipeline for predicting COVID-19 adverse outcomes 
 
Experimental Setup 
We used electronic health records data from over 14,500 patients with a confirmed case for 
COVID-19 between March and May 2020 and who had at least 1 year of medical history with 
Mass General Brigham (MGB), since 2016. Table 1S presents general demographic information 
about the study cohort. For each patient, we only included clinical records from 14 days prior to 
the positive COVID-19 test date. This temporal buffer ensures that no COVID-19-related 
medical conditions are included in the model as a risk factor. The use of data for this study was 
approved by the Mass General Brigham Institutional Review Board (2020P001063).  
 
We randomly split the data with an 80-20 training-to-testing ratio. We iterated the train-test 
sampling 10 times to account for possible patient population differences caused by the 
sampling. We used the tSPM algorithm to mine temporal sequential representations. Given a list 
of clinical records for patient  at times , the tSPM algorithmR , R , .., R1  2 .  n p t t .. i1 ≤  i2 ≤ . ≤ tiki
  
mines all avector of transitive sequential patterns from possible pairs of distinct recordsX ij  
 where  by setting (as samples of random variable for patient ) to be 1R , ),( i Rj = ,i / j ≤ n rij X ij p  
if and and 0 otherwise. We also mined raw representations from the clinical1, kki ≥   j ≥ 1 ,ti1 ≤ tji  
data, which are composed of all clinical records. To obtain a count of the raw records, for each 
patient , we sum the frequency of , as samples of a random variable .p , k , ...,k1  2  kn X i   
 
On the training sets, we performed feature and algorithm selection and the final predictive 
modeling. We feed the combined representations  to the feature selection step.X )X ′ = ( i ⋃ X ij i=j/  
Iterative feature and algorithm selection 
Unlike other studies that begin with a limited set of hypothetical risk factors, we took a primarily 
inductive approach to selecting clinical representations for predicting the risk of adverse 
outcomes in COVID-19 patients. First, we apply a filter method for feature selection, using a 
computational algorithm that minimizes sparsity and maximizes relevance (MSMR​16,17​). Step 1 in 
MSMR is to cut the initial combined vector of representations  to those that were observed inX ′  
fewer than 0.2 percent of the patients. On the remaining representations, step 2 in MSMR 
computes the mutual information with the outcome variable  which in this study(y , ..., y ),Y =  1   i  
includes labels for hospitalization, ICU, ventilation, and death. Mutual information,​18,19​ in this 
case, measures the amount of information that each remaining representation contains about 
the outcome. Given the joint probability distribution , the mutual information between(x , )P X Y′ ′ y  
them is denoted as is:(X )I ′ : Y  
(x , ) log∑
 
x y′
P X Y′ ′ y ×  
P (x ,y)X Y′ ′
P (x ) ×P (y)X′ ′ Y
  
 
We cut the remaining representations from by ranking based on the mutual informationX ′  
coefficient, and update  to a list of around 30,000 representations with the highest mutualX ′  
information. In the third and final step, MSMR computes the joint mutual information (JMI)​20 
score for the updated vector of remaining representations, . The algorithm starts with a set X ′ S
containing the top feature according to mutual information, then iteratively adds to the featuresS  
maximizing the joint mutual information score 
(X ) (X X ; )J jmi ′ =  ∑
 
X ∈ S′*
I ′ ′* Y   
Where the random variable corresponds to the joint distribution of and . As a result,XX ′ ′  * X ′ X ′*  
JMI also takes into account the redundancy between the features – i.e., reducing 
multicollinearity among covariates. Second, we combine the feature selection with a preliminary 
evaluation of algorithms for the prediction task. 
 
Using the <400 features identified by the MSMR algorithm, we train a set of preliminary 
classification algorithms that perform embedded feature selection. The preliminary classification 
serves two goals. First, we screened features used in those algorithms to compile a list of the 
common features used for modeling the 4 outcomes. Second, during each sampling iteration, 
we computed the Area Under the Receiver Operating Characteristic Curve (AUC ROC) on the 
held-out test sets to evaluate the algorithms’ performance for predicting the outcome labels. We 
used 10-fold cross-validation to train the prediction algorithm -- therefore, a 72-8-20, 
train-evaluation-test split. We tested 10 classification algorithms -- bartMachine: Bayesian 
Additive Regression Trees,​21,22​ Stacked AutoEncoder Deep Neural Network (dnn), Stochastic 
Gradient Boosting (gbm),​23,24​ glmboost: Boosted Generalized Linear Model, eXtreme Gradient 
Boosting (xgb)​25​ with DART booster (xgbDART),​26​ linear model solver (xgbLinear), tree learning 
(xgbTree), model-averaged Neural Network (avNNet), Elastic-Net regularized generalized linear 
model (glmnet),​27,28​ and Oblique random forest (ORFlog).​29  
Final classification 
The iterative feature and algorithm (preliminary classification) selection results in a set of 
common features and a ranking of classification algorithms. Using the top algorithms (by AUC 
ROC) and the common features, we perform a final round of classification training with 10 
train-test sampling iteration and 10-fold cross-validation. We also measured a model-specific 
feature importance/influence metric in the final modeling rounds.  
 
As we shall reveal in the results, the gbm algorithm was one of the top 2 performing algorithms. 
As a result, we computed the relative feature influence  metrics from the final gbm models to 
measure features’ importance.  In the gbm model, boosting estimates as an ‘additive’(X)F
︿
 
expansion of the form 
(X) h(X; )F
︿
= ∑
M
m=0
βm am   
Where the expansion coefficients and the base learner’s -- -- parameters {β }m 0
M (X; )h a {a }m 0
M
are jointly fit to the training data in a feedforward process. A regression tree model specializes 
tue base learner partitions the feature space into  disjoint regions to(X; )T m {R }jm
J
1
J {R }jm
J
j=1
 
predict a different constant value for each.​30​ The relative influence (or contribution),  averagesI j
2  
the improvement made by each variable when it is permuted from all trees in which the given 
variable was incorporated.​30,31​ In an additive tree model, the relative influence measure is 
provided by Friedman and Meulman (2003) 
(T )I j
2 =  1M ∑
M
m=1
I j
2
m  
where  is the measure of relevance for a single tree .​32(T )I j
2 T  
We summarize and report the AUC ROCs from the final models as well as the features’ relative 
influence values. 
Results  
Table 1S provides a summary of demographic characteristics of the patients. We found that 
among racial/ethnic groups, the rate of hospitalization, ICU admission, and ventilation was 
highest among African American/black individuals. The overall mortality rate was three percent, 
and white individuals had the highest rate (3.9 percent) compared to other racial/ethnic groups. 
Compared to females, male COVID-19 patients had a significantly higher chance of 
hospitalization, ICU admission, ventilation, and mortality. While the average age in the cohort of 
COVID-19 patients was 49.5, the average age of patients who were hospitalized, admitted to 
ICU, or needed mechanical ventilation was between 61 and 62. The average age of mortality in 
COVID-19 patients was much higher at 77 years (Table 1S).  
 
Figure 2 summarizes the sequential scenarios in which the four adverse outcomes are observed 
in COVID-19 patients. Overall, in more than 75 percent of the patients we did not observe any 
adverse outcomes. Approximately 13 percent of patients were discharged after hospitalization. 
The cumulative probability of patients needing to be admitted to the ICU was less than eight 
percent, which sorted in a declining order of sequential events from four percent to 1.4 percent 
for Hospitalized → ICU → Discharged, Hospitalized → ICU → Ventilation → Discharged, 
Hospitalized → ICU → Ventilation → Died. This order supports our general hypothesis about 
the severity spectrum. Of the three percent overall chance of mortality, 2.5 percent fall into the 
sequential scenarios of Hospitalized → ICU → Ventilation → Died and Hospitalized → Died 
(without ICU/Ventilation).  
 
Figure 2.​ Probability of the sequential scenarios for outcomes after COVID-19 infection. 
 
Iterative feature and algorithm selection 
MLHO mined over 60 thousand raw (e.g., diagnosis/medication/procedure codes) and 160 
million transitive sequential (e.g., medication → diagnosis) representations. Through the 
iterative feature selection, these features were shrunk to over 2,300 representations, about 900 
of which were raw features and about 1,400 were transitive sequential features. As described in 
the methods, both MSMR filter method and embedded methods (while training preliminary 
classification algorithms) were utilized in iterative sampling of train-test data. The other outcome 
of this step was identification of the top predictive algorithms. Figure 3 illustrates the AUC ROC 
results obtained from the 10 algorithms for estimating the risk of hospitalization. We found that 
two Boosting algorithms obtained the best overall results: the Stochastic Gradient Boosting 
(gbm) -- a.k.a., gradient boosting machine -- and the eXtreme Gradient Boosting (xgb) with 
DART booster (xgbDART) 
  
Algorithms from right to left: bartMachine: Bayesian Additive Regression Trees, dnn: Stacked 
AutoEncoder Deep Neural Network, gbm: Stochastic Gradient Boosting, glmboost: Boosted Generalized 
Linear Model, xgbDART: eXtreme Gradient Boosting (xgb) with DART booster, linear model solver 
(xgbLinear), tree learning (xgbTree), avNNet: model-averaged Neural Network, glmnet: Elastic-Net 
regularized generalized linear model, and ORFlog: Oblique random forest.  
Figure 3.​ AUC ROC result of the preliminary classification step for predicting hospitalization. 
Final modeling 
We fed the shrunken feature set (with ~2,300 features) to the two top algorithms for the final 
model training -- with 10 iterative train-test sampling and 10-fold cross-validation, which means 
for each outcome, we trained 20 final models. We picked the top 10 models, by AUC ROC. 
Table 1 presents the median, standard deviation, and the best AUC ROC values obtained from 
the final models for each outcome. Overall, the median AUC ROCs was the best for mortality, 
while it ranged near the 0.8 threshold for hospitalization, ICU, and ventilation. Among the top 10 
models, the gbm algorithm was the best algorithm for hospitalization and ICU, and the 
xgbDART was the best algorithm for predicting the need for mechanical ventilation. 
 
Table 1.​ The classification performance of the final models 
outcome median sd* best gbm xgbDART 
Mortality 0.912 0.002 0.915 3 7 
Hospitalization 0.801 0.002 0.807 10 0 
ICU 0.787 0.003 0.792 10 0 
Ventilation 0.831 0.003 0.838 0 10 
* standard deviation 
Features’ relative influence 
Because the relative influence measures from the gradient boosting models are relative, by 
default the largest value is assigned to 100, and the remaining values are scaled accordingly.​30 
Using only the non-zero relative influence values resulted in a final set of 603 features that were 
used for predicting at least one of the outcomes. Table 2S provides the list of features with their 
median and interquartile range values of relative influence by outcome.  
 
The features were then grouped under nine different clusters that correspond to comorbidities 
and demographics that have been associated with poor outcomes in COVID-19 by the Center 
for Disease and Control ​33​. The categories are cardiovascular disease, chronic renal disease, 
chronic lung disease, neurological disorder, diabetes mellitus, other chronic illness, age, sex, 
and race/ethnicity. The “Other chronic illness” cluster includes comorbidities such as 
hypertension, hyperlipidemia, hypothyroidism, obstructive sleep apnea, and obesity. 
 
Table 2 is a sample of features that were assigned to two of these disease clusters. The 
features used include diagnoses, medications, laboratory tests, imaging studies, and 
procedures. Diagnoses can easily be identified as a subtype of a particular category. For 
example, “Type 2 diabetes mellitus with diabetic nephropathy” is grouped with diabetes mellitus 
and “Unspecified dementia without behavioral disturbance” is grouped with neurological 
disorder. Medication labels are assigned to a specific cluster if the medication is exclusively 
used for that disease. For example, “metformin” is assigned to the diabetes mellitus cluster 
because it is primarily used for treating diabetes mellitus. However, in many cases a medication 
can be used for multiple diseases and cannot be easily grouped with a specific cluster. If a 
medication cannot be attributed to a specific cluster, it was left unassigned. 
 
For the sequential features, if one of the two components in the sequence was related to a 
disease cluster; the whole sequence was assigned to the corresponding disease. Laboratory 
tests, imaging studies and procedures on their own are not associated with a particular disease. 
But they were assigned to particular disease clusters if they were in sequence with another label 
that was specific to a disease cluster. For example, the sequence “CT Head → Altered Mental 
Status” was associated with a neurological disorder because it includes the diagnosis “Altered 
Mental Status”.  
 
 
 
 
 
 
 
 
Table 2.​ Sampling of select features used for identifying specific disease clusters (in this case 
Diabetes Mellitus and Neurological Disorder) 
 
Disease 
Cluster 
Diabetes Mellitus Neurological Disorder 
Diagnosis -Type 2 diabetes mellitus with 
diabetic chronic kidney disease 
-Type 2 diabetes mellitus with 
diabetic nephropathy 
-Unspecified Essential 
Hypertension-> Type 2 Diabetes 
Mellitus without complications 
-Unspecified dementia without behavioral 
disturbance 
-Cerebral infarction, unspecified 
-Essential (primary) hypertension -> 
Unspecified dementia without behavioral 
disturbance 
 
Medication -Metformin 
-Sodium Chloride 0.9% Injection 
Syringe -> Insulin Lispro 100 
unit/ml subcutaneous 
-Acetaminophen -> Unspecified dementia 
without behavioral disturbance 
Laboratory 
Test 
-Blood count; complete (CBC), 
automated and automated 
differential WBC count -> Injection, 
insulin, per 5 units 
Natriuretic peptide -> Altered Mental 
Status, unspecified 
-Basic Metabolic Panel (BMP) -> 
Unspecified dementia without behavioral 
disturbance 
Imaging 
Study 
-Type II Diabetes mellitus or 
unspecified type, not stated as 
uncontrolled, without mention of 
complication -> Electrocardiogram, 
routine ECG 
-Electrocardiogram, routine ECG -> 
Altered mental status, unspecified 
-CT Head -> Altered mental status, 
unspecified 
Procedure -Emergency Department Visit for 
Evaluation and Management -> 
Insulin 
- 
 
After assigning features to specific disease clusters the mean relative variable influence for the 
cluster was determined for each of the outcomes. Table 3 shows the relative influence of each 
of the clusters for determining hospitalization, ventilation, ICU admission, and death. Age was 
excluded from the table as it is by far the most predictive for each of the outcomes with a mean 
relative variable influence of  99.99.  Excluding age, the most influential clusters for the 
prediction of death are chronic lung disease, sex, neurological disorder, and race/ethnicity. The 
top predictors for ICU admission are sex, chronic renal disease, other chronic illness, and 
diabetes mellitus. The top predictive clusters for ventilation are sex, diabetes mellitus, race, and 
chronic renal disease. While for hospitalization, sex, race/ethnicity, other chronic illness, and 
diabetes mellitus, are the most predictive clusters. 
 
Table 3.​ Mean relative influence of the features associated with hospitalization, ventilation, ICU 
admission, and death 
 
Hospitalization Var.
Inf* 
Ventilation Var.
Inf 
ICU Var
.Inf 
Death Var.
Inf 
Sex (Female) 4.52 Sex (Female) 18.0
4 
Sex (Female) 9.5
7 
Chronic 
Lung 
Disease 
3.61 
Race/Ethnicity 3.93 Diabetes 
Mellitus  
4.21 Chronic 
Renal 
Disease 
1.8
9 
Sex 
(Female) 
3.44 
Other Chronic 
Illness 
0.45 Race/Ethnicity 3.65 Other 
Chronic 
Illness 
1.4
8 
Neurological 
Disorder 
3.27 
Diabetes 
Mellitus 
0.44 Chronic Renal 
Disease 
1.71 Diabetes 
Mellitus 
1.3
6 
Race** 3.06 
Cardiovascular 
Disease 
0.41 Other Chronic 
Disease 
1.63 Chronic Lung 
Disease 
0.7
4 
Chronic 
Renal 
Disease 
2.16 
Chronic Renal 
Disease 
0.20 Chronic Lung 
Disease 
1.33 Cardiovascul
ar Disease 
 
0.3
7 
Cardiovascul
ar Disease 
1.84 
Neurological 
Disorder 
0.04 Cardiovascula
r Disease 
0.95   Diabetes 
Mellitus 
1.52 
  Neurological 
Disorder 
0.51   Other 
Chronic 
Illness 
1.31 
* Mean relative variable influence -- relative influence values are scaled between 0 to 100.  
** The race category is an aggregation of races White and Black or African American. Details 
are available in Table 2S. 
Discussion  
Using the MLHO pipeline, we developed models for predicting risks of hospitalization, ICU 
admission, need for mechanical ventilation, and death for patients infected with COVID-19. We 
were able to model the four adverse outcomes with about 600 features from patients’ past 
medical records, before they contracted COVID-19. MLHO can leverage the past medical 
records in clinical repositories to quickly develop predictive models with acceptable accuracy. 
One could envision different applications for such predictions. For example, we could aggregate 
MLHO’s predictions based on a population’s expected rates of infection during a pandemic, to 
better allocate healthcare resources in preparation for a surge in cases. It would also help 
allocate the number of critical care nurses and doctors, ventilators, hospital beds, and supplies 
in the case of a resurgence of the pandemic.  
 
Being able to predict the four outcomes can also create possibilities for better preventive 
measures. For instance, healthcare systems and regional health authorities can use predicted 
outcomes to identify patients who might be at higher risks and plan for preventive measures 
such as alerting the patients’ primary care providers to prioritize healthcare maintenance visits in 
order to make sure the patients are up to date on immunizations and health care screening. 
There could also be an in-person discussion of the importance of taking precaution against 
contracting COVID-19. The estimated risks provided by MLHO can also help stratify the most 
at-risk from already known vulnerable populations such as those living in nursing homes, 
subacute rehabilitation centers, and homeless shelters for potential high risk. 
 
We found that the average age for patients who died was about 77, whereas the average age 
for hospitalization, ventilation, and ICU admission was around 61. This shows that the patients 
hospitalized and having critical illness interventions (such as an ICU admission or intubation) in 
general have a younger age. One possible explanation for this discrepancy is that many of the 
younger patients with these interventions may survive. This suggests that the younger patients 
who get intensive therapies such as ventilation or admission into the ICU, see an improvement 
compared to the older patients who may have less improvement with such therapies. 
 
The relative influence of specific disease clusters for different outcomes suggests certain 
diseases may have increased predictive value for determining adverse outcomes. Age is by far 
the best predictor for an adverse outcome. It is far more influential of the prediction than any 
other comorbidity or demographic including severe diseases such as congestive heart failure, 
end stage renal failure, or dementia. Another interesting trend between outcomes is that chronic 
illness (hypertension, hypothyroidism, and obesity) and diabetes mellitus are relatively more 
influential predictors for hospitalization, ICU admission, and need for ventilation than they are for 
death. However, the comorbidity with the best prediction for death is chronic lung disease. This 
could suggest that intensive therapies such as ventilation and admission into the ICU, may 
improve the outcome of patients with common comorbidities such as hypertension and 
hyperlipidemia but they do not have as beneficial of an impact on patients with chronic lung 
disease.  
 
Findings of this study can exhibit limitations due to the potential availability of noise in outcome 
labels. Outcomes such as hospitalization, ICU admission, and ventilation can be difficult to 
uniformly measure since they can be correlated with healthcare utilization. For example, 
hospitalization could be due to a heart failure exacerbation and the COVID-19 diagnosis is only 
incidentally discovered, but unrelated to the hospitalization. 
 
Conclusion  
The COVID-19 pandemic has had devastating health and economic impacts across the globe. 
Being able to predict adverse outcomes that directly impact the capacity of healthcare systems 
in a timely manner can lead to better allocation of healthcare resources and more efficient 
targeted economic and preventive measures. MLHO’s architecture enables a parallel 
outcome-targeted calibration of the features and algorithms, in which different statistical learning 
algorithms and vectors of features are simultaneously tested and leveraged to improve 
prediction of health outcomes. As the COVID-19 cases are re-surging around the world, a 
pipeline like MLHO is crucial to improve our readiness for confronting not only the potential 
future waves of COVID-19, but also other novel infectious diseases that may emerge. 
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